Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407
J Thorac Oncol 2021 Nov 01;16(11)1883-1892, SF Powell, D Rodríguez-Abreu, CJ Langer, A Tafreshi, L Paz-Ares, HG Kopp, J Rodríguez-Cid, DM Kowalski, Y Cheng, T Kurata, MM Awad, J Lin, B Zhao, MC Pietanza, B Piperdi, MC GarassinoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.